The FDA has approved Finesse, an insulin patch-pen from Calibra Medical, for up to three-day use with Novolog (insulin aspart, from Novo Nordisk). Finesse is a bolus-only, adhesively attached, flat plastic patch-pen device that measures approximately 2 inches long, one inch wide, and one-quarter inch thick. Finesse may be filled with up to three days of insulin. It is designed to be worn on the skin like a bandage and delivers insulin through a flexible plastic tube that is inserted into the skin after the device is filled. Finesse is already approved for use with Humalog (insulin lispro, from Lilly).
For more information call (650) 216-7722.